Delivery Order SPE2DB22D3301-SPE2DB24FZ3UW

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for Telmisartan 80 mg Tablets, a prescription medication, with a ceiling value of $1,062.40 and an ultimate completion date of August 12, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a total ceiling value of $40,017.75 and a completion date of October 21, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has a ceiling value of $9,207.44 and a completion date of July 15, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,845.14 to Amerisourcebergen Drug Corp's Corporate Office Division on June 7, 2024. The contract is for the supply of Telmisartan 80 mg tablets in 30-count packages, with a completion date of June 10, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a ceiling value of $2,193.71 and a completion date of December 28, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565416668 Telmisartan-HCTZ 40-12.5 mg tablets in units of 30's. The contract is valued at $3,378.72 and has a completion date of August 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,561,153,990 units of Telmisartan 80 mg tablets in 30-count packages, with a ceiling value of $1,677.74 and a period of performance ending on June 7, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $3,521.90 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The delivery order has an ultimate completion date of August 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.87, is for the delivery of Telmisartan 20 mg tablets in 30-count packages. The contract has a period of performance through March 5, 2025 and utilizes a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of Telmisartan 20 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a ceiling value of $1,258.13. It does not have a set-aside designation. Amerisourcebergen Drug Corporation is the prime contractor,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3UW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of 4565634300 - Telmisartan 20 mg Tablet 30s, a pharmaceutical product. The contract has a ceiling value of $2,148.29 and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/28/24, 9:21 AM